Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Z102 in moderate to severe rheumatoid arthritis
NCT01612377Phase 2Terminated
- Sponsor
- CombinatoRx
- Start
- Mar 2012
- Primary completion
- Jul 2013
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of prednisolone + dipyridamole in rheumatoid arthritis (RA), sponsored by CombinatoRx. Started Mar 2012; status: terminated.
02
Drugs
prednisolone + dipyridamole
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT01612377.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01612377.